| Affiliation: | 1. Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada;2. Schulich School of Medicine and Dentistry, Western University, London, Canada;3. Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil;4. Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil;1. Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Switzerland;2. Neuro-imaging Center, University of Groningen, University Medical Center Groningen, the Netherlands;3. Neuroscience Center Zurich, Zurich, Switzerland;4. Department of Psychology, University of Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, the Netherlands;1. Institute for Health Metrics and Evaluation, University of Washington, 3980 15th Ave NE, Seattle, WA 98195, USA;2. Center for Alzheimer Research, Karolinska Institutet, Stockholm 17177, Sweden |
